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Friend Murine Leukemia Viruses by the Mouse Rmcf
Gene Is Governed by the Viral Long Terminal Repeat
By B. Kay Brightman, Qi-Xiang Li, David J . Trepp, and Hung Fan
From the Department ofMolecular Biology and Biochemistry and Cancer Reseanh Institute,
University of California, Irvine, California 92717
Summary
Neonatal CxD2 (Rmcf) and Balb/c (Rmcf) mice inoculated with Moloney murine leukemia virus
(M-MuLV) exhibited approximately equivalent time course and pathology for disease. CxD2
mice showed only slightly reduced presence ofMoloney mink cell focus-forming virus (M-MCF)
provirus as seen by Southern blot analysis compared to Balb/c mice. This lack of restriction for
disease and spread of MCF was in sharp contrast to that seen for CXD2 mice inoculated with
Friend murine leukemia virus (F-MuLV), where incidence of disease and propagation of MCFs
were severely restricted, as previously reported . - Inoculation of CxD2 mice with FM-MuLV, a
recombinant F-MuLV virus containing M-MuLV LTR sequences (U3 and R), resulted in T cell
disease of time course equal to that seen in Balb/c mice ; there also was little restriction for propagation
of MCFs. This indicated that presence of the M-MuLV long terminal repeat (LTR) was sufficient
for propagation of MCFs in CxD2 mice. Differing restriction for F-MuLV vs. M-MuLV in CxD2
mice was' explained on the basis of different "MCF propagator cells" for the two viruses . It
was suggested that cells propagating F-MCF (e.g., erythroid progenitors) are blocked by endogenous
MCF-like gp70-° protein, whereas cells propagating M-MCF (e.g., lymphoid) do not express
this protein on their surface. F-MuLV disease in CxD2 mice was greatly accelerated when
neonates were inoculated with a F-MuLV/F-MCF pseudotypic mixture. However, F-MCF provirus
was not detectable or only barely detectable in F-MuLV/F-MCF-induced tumors, suggesting that
F-MCF acted indirectly in induction of these tumors .
oloney murine leukemia virus (M-MuLV)l induces T
cell lymphoma with a typical latency of3-4 mo when
inoculated into neonatal mice. One of the events observed
in M-MuLVinduced disease is the appearance of mink cell
focus-forming (MCF) viruses, which result from recombi-
nation of the input ecotropic virus with endogenous poly-
tropic retroviral sequences (1, 2) . In mice, MCF proviruses
are found in M-MuLVinduced tumors (3-5), and are also
observed at significant circulating titres at preleukemic times
(6) . They have been proposed to be the "proximal leukemo-
gens" in MuLVinduced disease (7-9) . We have recently
reported evidence that MCFs may also play a role early in
M-MuLVinduced leukemogenesis, by participating in induc-
tion of preleukemic hematopoiesic hyperplasia of the spleen
(5, 10) . The proposed role of MCFs in this process was to
'Abbreviations used in this paper. M- and F-MuLV Moloney and Friend
murine leukemia virus, respectively ; M- and F-MCF, Moloney and Friend
mink cell focus-forming virus, respectively ; FM-MuLV, a molecularly cloned
F-MuLV recombinant containing the long terminal repeat of M-MuLV;
LTR, long terminal repeat ; Rmcf I and RmcfJ, resistance and sensitivity
alleles, respectively, of the Rmcfgene.
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induce suppression of bone marrow hematopoiesis by com-
bined infection with M-MuLV, leading to compensatory ex-
tramedullary hematopoiesis in the spleen .
To investigate further the role ofMCF viruses in M-MuLV-
induced disease, we employed a strain of partially congenic
Balb/c mice carrying the resistance allele of the Rmcf gene
(Rmcf) developed by Potter et al . (11) . The Rmcf locus was
first described by Hartley et al . (9) ; Rmcf mice are resistant
to rapid development of Friend MuLV (F-MuLV) induced
erythroleukemia (12, 13) . Fibroblast cell cultures derived from
certain (Rmcf) strains of mice are resistant to infection by
MCFs but not ecotropic MuLVs (9, 14) . Resistance is cor-
related with cell surface expression of an endogenous MCF-
related gp70 (SU) protein (12-15) . It has been hypothesized
that expression of this protein in Rmcf mice interferes with
spread of in vivo-generated MCFs due to blockage of MCF
receptors by the endogenous MCF-related gp70. Indeed, MCFs
propagate poorly or not at all in Rmcf mice inoculated with
F-MuLV (12, 13) . The Rmcf gene may code for the MCF-
related gp70 (16) or, alternatively, for a gene affecting ex-
pression of endogenous MuLV-related proviruses (16, 17) .
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In the experiments described in this report, we tested
the effects of M-MuLV in Rmcf mice . Since Friend and
Moloney MCFs share the same receptor as measured in in-
terference assays (18), it seemed likely that Rmcf mice would
be resistant to in vivo-generation of M-MCF and that they
would be relatively resistant to M-MuLV-induced leukemia .
Moreover, MCF-driven preleukemic events might not occur
in M-MuLVinfected Rmcf animals. We report here that
there is significantly less restriction for M-MuLV leukemo-
genesis and MCF generation and propagation in Rmcf mice
than is the case for F-MuLV-inoculated Rmcf mice and that
the difference is governed by the LTR. A model to explain
this difference is presented .
Materials and Methods
Viruses and Cell Lines.
	
Generation ofa molecularly cloned viral
stock ofM-MuLV was described previously (19) . For M-MCF, ei-
ther Mo-MCF,-1 or MCFMoLTR viral stock was used . Mo-
MCF,-1 contains only one copy of the 75-bp direct repeat of the
M-MuLV enhancer (20) while MCFMoLTR contains two direct
repeats . MCFMoLTR was generated by molecular cloning in which
the Xho I-Cla I fragment of the M-MCF, genome (1 .5 kb to 7.6
kb on the proviral map, encompassing the 3' half of gag, all of
pol, and the SU portion of env) was exchanged at the same sites
into an infectious M-MuLV provirus clone . Infectious virus was
then recovered by transfection of the MCFMoLTR clone into NIH-
3T3 cells. Pathology data reported in Fig. I are that ofMCFMoLTR.
The F-MuLV and F-MCF producer cell lines were the kind gift
of Sandra Ruscetti (NIH, Bethesda, MD) (12) . FM-MuLV (21) was
kindly provided by Nancy Hopkins (MIT, Cambridge, MA). Pseu-
dotypic viral stocks were obtained by superinfection of cells pro-
ducing one MuLV with an MuLV ofa different interference group.
Viral titers ranged from 10^ to 106 infectious U/ml as determined
by reverse transcriptase assay (for pseudotypic mixtures) (22) or
UV/XC assay (23) (for ecotropic virus alone) . All cells were grown
in DMEM plus 10% calf serum .
Inoculation ofMice. Partially congenic Balb/c mice carrying the
resistance allele of the Rmcf gene (CxD2 ) (11, 16) were the
generous gift of Sandra Ruscetti . These mice were interbred after
the 5th generation backcross of (DBA/2 x Balb/cAnPt)F, x
Balb/cAnPt (16) . Neonatal CxD2 (Rmcf) or Balb/cAnPt (Rmcf)
mice were inoculated intraperitoneally with 0.2 ml viral superna-
tant and sacrificed when moribund .
Southern Blot Analysis. DNA was obtained from tumor spleno-
cytes and thymocytes as described previously (24, 25). Southern
blot procedures were performed using Gene Screen Plus (New En-
gland Nuclear, Boston, MA), hybridized in 50% deionized forma-
mide, 1% SDS, 1 M NaCl, 10% dextran sulfate at 42°C, followed
by two 30 washes at 65°C in 1xSSC + 1% SDS and two 30 washes
at room temperature in 0 .1 x SSC according to manufacturer's
specifications. Blots were then exposed to Kodak XAR-5 film at
-80°C. Fragments used for P' 2-labeled random primer probes
were as follows : the 700-bp Bam HI-Eco RI fragment from
M-MCF,-1 (20) ; the x+400-bp Ava I-Eco RI fragment from the
F-MCF Clavaco clone (kindly provided by Alan OlifF, Merck and
Co., Rahway, NJ) (26) ; the 8.2-kb Eco RI fragment including the
entire 1-LTR permuted F-MuLV genome from F-MuLV Clone 57
(27) ; the 600-bp Eco RI fragment from 86T5 (28), a cDNA clone
for the T cell receptor (3 chain locus .
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Results
Differential Restriction by the Rmcf Gene
Disease Induction in Rmcf Mice by M-MuLV. To inves-
tigate the role of MCFs in M-MuLVinduced disease, neo-
natal Balb/c mice carrying the Rmcf allele from DBA/2
mice (CxD2) (11, 16) were inoculated intraperitoneally with
M-MuLV as described in Materials and Methods . Wild-type
Balb/c mice, which are sensitive to infection by MCFs
(Rmcf), were inoculated in parallel as controls. CXD2 mice
are the fifth generation backcrosses of Balb/c x (Balb/c x
DBA/2) selected for the Rmcf allele; thus, they are partially
congenic to Balb/cAn mice. Since F-MuLV and AKRderived
MCF viruses propagate poorly in mice carrying the Rmcf
gene (8, 12, 13, 16), and since these MCFs and M-MCF share
the same receptor in NIH-3T3s (18), we expected that M-MCF
would be restricted in these mice as well . Theoretically, this
would allow us to test whether inhibition of MCP genera-
tion changes the time course or disease frequency induced
by M-MuLV. Surprisingly, time course of disease was essen-
tially the same for the Rmcf (CxD2) mice in comparison
with Rmcf Balb/c mice as seen in Fig . 1, upper panel. Both
Rmcf and Rmcf mice inoculated with M-MuLV died with
an average latency of approximately 16 wk. Moribund mice
all exhibited enlarged thymus, spleen, and lymph nodes as
described previously for M-MuLV-inoculated NFS and NIH
Swiss mice (19, 29) .
The unexpected sensitivity of the Rmcf mice to M-MuLV
leukemogenesis raised the possibility that these mice no longer
carried the Rmcf allele . Therefore, we also inoculated
(CXD2) (Rmcf) and Balb/c (Rmcf) mice with F-MuLV. As
shown in Fig. 1, lower panel, F-MuLVinoculated Rmcf
mice exhibited an average time to death of 9 wk with 100%
dying by 19 wk, whereas 50% of the Rmcf mice were still
living at 37 wk. These results were consistent with those
observed by others previously for Rmcf and Rmcf mice (13,
16), and confirmed that our CxD2 mice still contained the
Rmcf allele. Thus, M-MuLV disease is not subject to restric-
tion by the Rmcf allele in the Rmcf mice used in these ex-
periments, while F-MuLV disease is.
M-MCF Generation and Propagation in Rmcf Mice. Since
F-MCF was previously shown to propagate poorly or not
at all in F-MuLV-inoculated Rmcf mice (12, 13), it was im-
portant to determine if the lack of Rmcf restriction for
M-MuLV pathogenesis was associated with a lack of restric-
tion for M-MCF propagation . We tested for the presence
of M-MCFs in M-MuLV-induced tumors from Rmcf mice
by Southern blot analysis as shown in Fig. 2 A . An M-MCF
provirus resulting from recombination between the input
ecotropic M-MuLV and endogenous polytropic sequences
would contain a Bam HI site derived from the polytropic
genome at the 5' end of the MCF env region and retain the
Xba I site in the 3' LTR of the M-MuLV parent . Therefore,
digestion ofDNA with Bam HI plus Xba I will yield a unique
diagnostic 2.3-kb fragment hybridizable with an HCF env
probe if an M-MCF provirus is present (5) . As shown in Table
1 and Fig. 2 B, 8/9 or 89% of tumor DNAs from M-MuLV
inoculated Rmcf mice readily showed the MCF-specific
band . Thus, M-MCFs could generate and propagate in
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Figure 1.
	
Neonatal CxD2 (Rmcf) or Balb/c (Rmcf) mice were inocu-
lated i .p. with M-MuLV or F-MuLV as indicated by legends next to the
panels. Number of animals for each inoculum and strain is indicated in
parentheses. In addition, a pseudotypic mixture of either M-MuLV/M-
MCF (MCFMoLTR) or F-MuLV/F-MCF was inoculated into CxD2 mice
(CxD2+MCF) . Animals were sacrificed when moribund . pathogenicity
of the different inoculums in the two strains is shown .
M-MuLV-infected Rmcf mice. Parallel Southern blot anal-
ysis of M-MuLV tumors induced in Balb/c mice indicated
that 100% of these tumors were positive for MCF provirus
(data not shown) .
Table 1 . MCF Provirus in Moribund CxD2 (Rmcf`) and
Balb/c (Rmcf) Mice*
* MCF was detected in tumor DNAs by digestion with Xbal + Bam
HI for M-MCF and FM-MCF or Eco RI for Fr-MCF followed by
Southern blot analysis as described in the Figures and Materials and
Methods . r - resistant ; s - sensitive .
t Diagnostic band barely detectable by Southern blot analysis .
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The presence of F-MCFs in Rmcf mice has been inves-
tigated in previous reports by infectious center assays or by
immunoprecipitation of a gPr80 MCF envelope polyprotein
precursor (12, 13, 16), and the results were negative. It was
important to compare the sensitivity of the results obtained
by the previous assays with the Southern blot analyses for
MCF provirus in Fig. 2 . Therefore, we examined Rmcf
tumors induced by F-MuLV after long latency for the pres-
ence of F-MCF. For detection of F-MCF, Eco RI digestion
will yield a diagnostic 3.5-kb fragment spanning the pol and
env regions which hybridizes with an F-MCF probe. As seen
in Fig. 2 C, F-MuLV-induced tumors in CxD2 mice showed
no evidence for MCFs, even though F-MuLV provirus was
easily detected by separate Southern analysis using an F-MuLV
probe (data not shown) . Thus, the Southern blot assay was
in agreement with previous assays, and the results for Fig . 2
indicated that M-MCF formation and propagation is not re-
stricted to the same extent as for F-MCFs in Rmcf mice. We
also examined three tumors induced in Balb/c (Rmcf) mice
inoculated with F-MuLV. All contained F-MCF provirus
(Fig. 2 D). These results indicated that failure of F-MCF to
generate or propagate in CxD2 mice was due to the Rmcf
allele of the Rmcfgene, as reported . Furthermore, the Rmcf
allele may also have provided slight resistance to spread of
M-MCF, since one M-MuLVinduced tumor in CxD2 mice
failed to show evidence by this analysis of MCF proviruses .
Genomic Sequences Requiredfor Propagation ofM-MCF. The
ability of M-MCFs to propagate in Rmcf mice in contrast
to F-MCFs was quite striking . We wished to determine the
regions of the M-MuLV and F-MuLV responsible for the
differential generation and/or propagation ofthe corresponding
MCFs in Rmcf mice. Even though M-MCF and F-MCF are
of the same receptor-binding class with respect to NIH-3T3
fibroblasts (18), it was formally possible that the M-MCF
and F-MCF envelope glycoproteins bind MCF receptor(s) with
different affinities such that M-MCF is not subject to superin-
fection resistance by the endogenous MCF-related gp70 on
Rmcf cells, while F-MCF is . Alternatively, the differing be-
haviors of F-MCF and M-MCF in -Rmcf mice could result
from differences in LTR enhancer activities. The different
pathogenic specificities of F-MuLV and M-MuLV have been
mapped to the enhancers in the LTRs (21) . To test these hy-
potheses, we made use of a molecularly cloned recombinant
between M-MuLV and F-MuLV, FM-MuLV (30) . FM-MuLV
contains the U3-R region of the M-MuLV LTR (including
the enhancers and promoter) with the remainder of the ge-
nome derived from F-MuLV. FM-MuLV induces T lymphoid
leukemia, due to the presence of the M-MuLV enhancers (30,
31) . FM-MuLV was inoculated into CXD2 and Balb/c neo-
natal mice, and the results are shown in Fig. 3 . The time
course of disease did not vary significantly for FM-MuLV in-
oculated into Rmcf versus Rmcf mice as seen in Fig. 3 and,
in fact, was similar to that seen for wild-type M-MuLVin-
oculated mice. All moribund mice displayed gross pathology
typical ofM-MuLVinduced T lymphoma, as described above.
In addition, T cell receptor beta chain analysis (24, 32)
confirmed that tumor cells were of T cell origin (Fig. 4) .
Southern blot analysis was performed to investigate the pres-
Strain Virus No . MCF+/Total %MCF+
(%)
CxD2 M-MuLV 8/9 89
Balb/c M-MuLV 13/13 100
CxD2 Fr-MuLV 0/4 0
Balb/c Fr-MuLV 3/3 100
CxD2 FM-MuLV 7/9 78
Balb/c FM-MuLV 7/7 100
CxD2 MuLV/M-MCF 5/5 100
CxD2 Fr-MuLV/Fr-MCF 4/6t 67t
Figure 2 .
	
Detection of MCF provirus by Southern blot analysis. (A) Restriction maps of M-MuLV F-MuLV, and expected M- and F-MCFs derived
from recombination between the respective inoculated ecotropic virus and endogenous polytropic sequences . M-MCF recombinants are detected by
the diagnostic 2.3-kb Bam HI/Xba I fragment ofthe M-MCF env region (5) . F-MCF recombinants are detected by a diagnostic 3.5-kb Eco RI fragment
of the F-MCF pol-env region. These bands detected using an M- or F-MCF-specific probe as described in Materials and Methods . X - Xba I ;
B - Bam HI; R - Eco RI . (/) - MCF-specific envelope sequences . (B) M-MuLVinduced CxD2 (Rmcf) tumor DNAs digested with Xba I plus Barn
HI, separated by gel electrophoresis, and analyzed by Southern blot hybridization with an M-MCF-specific probe. Lane a - uninoculated CxD2 mouse
DNA; Lanes b-g - representative thymic tumor DNAs from six M-MuLVinoculated moribund CxD2 mice . Left arrow indicates diagnostic band .
(C) F-MuLVinduced CxD2 tumor DNAs digested with Eco RI and hybridized with a F-MCF-specific probe . Lane a - uninoculated CxD2 mouse
DNA; Lanes b and c - F-MuLV and F-MCF producer cell line DNAs, respectively ; Lanes d-g - thymus and spleen DNAs, respectively, for two
F-MuLVinoculated moribund mice, and lanes h-i - spleen tumor DNAs only from two additional mice. (D) F-MuLVinduced Balb/c (Rmcf) tumor
DNAs digested and hybridized as for panel C . Lane a - Uninoculated Balb/c splenocyte DNA; Lane b - F-MCF producer cell line showing expected
F-MCF-specific band (arrow) ; Lanes c-e - three F-MuLVinduced Balb/c tumor DNAs .
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Figure 3 . Disease induced by FM-MuLV in CXD2 and Balb/c mice .
FM-MuLV (21) (which contains the U3-R region of M-MuLV and U5
and coding sequences of F-MuLV) was inoculated i .p . into neonatal CxD2
(Rmcf) or Balb/c (Rmcf) mice, and animals were sacrificed when mori-
bund . Pathogenicity in the two strains is shown .
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ence of MCFs in tumors from FM-MuLV-inoculated mice .
An FM-MCF would generate the same diagnostic 2.3-kb Xba
I/Bam HI fragment as for M-MCF (Fig. 2), since the FM-
MCF would contain the Xba I site in the M-MuLV LTR
and the Bam HI site is present in the MCF-specific env se-
quences introduced in the recombination event . Fig . 5 A and
B show that both Rmcf and Rmcf mice could generate
MCF recombinants after inoculation with FM-MuLV. 7/9
Rmcf and 7/7 Rmcf mice inoculated with FM-MuLV were
positive for MCF provirus . These results indicated that the
presence of the M-MuLV LTR was sufficient for generation
and propagation of MCFs and induction of rapid disease in
Rmcf mice, even when all other viral determinants were
from F-MuLV.
Acceleration of M- or F-MuLV Disease in Rmcf Mice by
MCF. It has previously been reported that inoculation of
F-MCF pseudotyped with F-MuLV did not cure the defect
for F-MuLVinduced early erythroid disease in Rmcf mice
Figure 4 .
	
TCRs gene rearrangement in FM-MuLVinduced tumors. Tumor DNAs were digested with Hpa I and analyzed by Southern blot hybrid-
ization with a TCRs constant region probe (28) as described in Materials and Methods . Lane 1 - uninoculated CxD2 mouse DNA showing expected
germline bands of 11 .6 and 6 .1 kb ; Lanes 1 and 3 - tumor DNAs from FM-MuLVinoculated CxD2 (Rmcf) mice; Lane 4 - uninoculated Balb/c mouse
DNA; Lanes 5-11 - tumor DNAs from FM-MuLVinoculated Balb/c (Rmcf) mice .
(12) . However, the potential effect of such a pseudotypic mix-
ture on F-MuLVinduced disease of longer latency has not
been investigated . We inoculated neonatal CxD2 mice with
a pseudotypic mixture of either F-MuLV/F-MCF or M-MuLV/
M-MCF. Slight acceleration by M-MCF of M-MuLVinduced
disease (2-3 wk) was observed in CxD2 mice (Fig . 1, upper
393 Brightman et al .
Figure 5. Detection ofMCFs in FM-MuLVinduced CXD2 and Balb/c
tumors . DNAs were analyzed by Southern blot hybridization as in Fig.
2 B for the M-MCF-specific band using the M-MCF-specific probe (arrow).
(A) Lane 1 - NIH-3T3 cell line DNA; Lane 2 - NIH-3T3-based M-MCF
producer cell line (MCFMoLTR) ; Lane 3 - NIH-3T3-based FM-MuLV
producer cell line; Lanes 4-8 - FM-MuLVinduced CxD2 tumor DNAs.
The diagnostic MCF band was present in lanes 5-8 . (B) Lanes 1 and
2- FM-MuLV and MCFMoLTR producer cell line DNAs, respectively,
as in panel A; Lane 3 - uninoculated Balb/c mouse spleen DNA ; Lanes
4-8- FM-MuLVinduced Balb/c tumor DNAs; Lane 9 - DNA from FM_
MuLVinoculated 8-wk-old Balb/c mouse . (C) Restriction maps of FM-
MuLV and the expected FM-MuLV MCF arising through recombination
of the input virus with endogenous proviral env sequences . FM-MuLV
contains the Xba I site in its LTR derived from M-MuLV Thus -an FM-
MCF would generate the same diagnostic 2 .3-kb XbaI/Barn HI fragment
as for M-MCF.
panel) . For F-MuLV-induced disease in Rmcf mice, average
time to death was decreased by addition of F-MCF to nearly
half-from 30 to 16 wk (Fig. 1, lowerpane . Gross pathology
of the disease induced by the F-MuLV/F-MCF inoculum ap-
peared. similar to that of F-MuLV alone in Rmcf' mice with
greatly enlarged spleen and normal or regressed lymph nodes
and thymus. Southern blot analysis on F-MuLV/F-MCF-in-
duced tumor DNAs revealed a faint MCF diagnostic band
(indicating low copy number) in 4/6 tumors examined and
this band was undetectable in the remaining tumors (not
shown) . Thus, while F-MCF accelerated F-MuLVinduced
leukemia, direct infection by F-MCF of the majority of the
resulting tumor cells was apparently not required .
Discussion
In these experiments, the pathogenesis of M-MuLV in mice
carrying the Rmcf' and Rmcf alleles was compared by in-
fecting CxD2 vs . Balb/c mice . In contrast to F-MuLV,
M-MuLV showed no significant difference in leukemia time
course in Rmcf' vs. Rmcf mice, and the majority of tumors
developing in Rmcf' CxD2 mice showed evidence of MCF
proviruses. Thus, M-MuLV was much less sensitive to the
Rmcf-mediated restriction in vivo than F-MuLV. These
results were initially surprising, since considerable evidence
for the involvement of MCF recombinants in M-MuLV patho-
genesis has been reported (3, 4, 5, 10) . Moreover, since
M-MCFs and F-MCFs bind to the same cellular receptor (18),
it might seem that leukemogenesis by M-MuLV should be
restricted in Rmcf mice to the same degree as F-MuLV. In-
deed, this was the initial motivation for our experiments.
The different restrictions of the Rmcf' gene for M-MuLV
and F-MuLV might result from two possibilities. First, it is
possible that F-MCF and M-MCF glycoproteins might have
different affinities for the cellular MCF receptor. If F-MCF
had a lower affinity than M-MCF, the endogenous MCF-
like gp70 expressed in Rmcf cells might competitively block
binding of F-MCF virus particles, but not M-MCF parti-
cles. A second possibility could be that enhancer differences
between M-MuLV and F-MuLV (dictated by the LTRs)
mediate the different responses . The experiments with FM-
MuLV clearly support the second possibility, since this virus
has the structural genes of F-MuLV, but the LTR ofM-MuLV,
and it is not restricted by the Rmcf' gene .
To interpret these results, it is important to consider that
at early times, most MCF particles probably also have MCF
envelope proteins, i.e., pseudotyping of MCF genomes with
ecotropic env proteins is probably rare due to the low mul-
tiplicities ofinfection in vivo at this time . (Other experiments
support this notion [5] .) Thus, MCF viruses would propa-
gate in vivo in "MCF propagator" cells : cells with (a) sur-
face MCF receptors (18, 33) and (b) transcriptional milieus
compatible with the viral LTR of the infecting virus (6, 21,
30, 34, 35) (Fig . 6 A) . MCP propagators could be either he-
matopoietic or non-hematopoietic cells.
The differential restriction of F-MuLV and M-MuLV in
Rmcf mice could be explained if there existed (a) nonequiva-
lent sets of F-MCF vs . M-MCF propagator cells, and (b)
differential tissue-specific expression of endogenous MCF-like
gp70. In particular, for F-MuLV in Rmcf mice, MCF propa-
gators probably include erythroid and myeloid hematopoi-
etic cells, fibroblasts and stromal cells, since the F-MuLV LTR
is active in these cell types (9, 12, 27, 36), and in vivo and
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Figure 6 . A proposed model for differential in vivo propagation of M-
MCF and F-MCF in CxD2 mice. (A) Early stages in propagation of MCF
viruses. MCF propagators must have MCF receptors (and potentially
ecotropic receptors as well) on their cell surface and the MCF LTR must
be active in these cells. Propagators could be adherent or hematopoietic
cells . (B) Tissue-specific expression of the (Rmcf-induced endogenous
MCF-like gp7(k°" could explain Rmcf-mediated resistance to F-MCF, but
not M-MCF (see text) . L, M, S, F, and E - lymphoid, myeloid, bone marrow
stroma, fibroblast, and erythroid cells, respectively.
in vitro experiments suggest that many of these have surface
MCP receptors (9, 15, 16) (Fig . 6B, upperpanel) . If all potential
F-MCF propagators are expressing endogenous MCF gp70
in Rmcf mice, they would be blocked for F-MCF infection
(Fig . 6 B, lowerpanel) and propagation . On the other hand,
M-MuLV could generate M-MCFs in Rmcf mice (and cause
rapid disease) if at least some M-MCF propagators did not
express Rmcf-controlled endogenous MCF gp70 . Lymphoid
cells would be candidates for such cells ; they would not be
F-MCF propagators in either Rmcf or Rmcf mice because
they do not efficiently support transcription from the F-MuLV
LTR (37-39) (Fig . 6 B, lower panel) . This model also would
explain the behavior of FM-MuLV in Rmcf mice : an FM-
MCF would be able to propagate in the same cells that an
M-MCF can (e.g ., a lymphoid cell), since it contains the same
LTR as M-MCF.
Previous results of Buller et al . (15) strongly support the
model in Fig . 6 . These investigators showed that expression
of endogenous MCF-like gp70 in Rmcf mice is found pre-
dominantly on erythroid cells and to a lesser extent on my-
eloid and lymphoid progenitors . Notably, 90-95% of Rmcf
mouse thymocytes do not express the endogenous gp70 .
While the Rmcf gene did not delay the time course of
leukemogenesis for M-MuLV or FM-MuLV in CxD2 mice,
there may have been slight blockage in MCF formation, since
one tumor did not show evidence for MCFs. According to
our model, it is quite likely that some M-MCF propagator
cells are blocked in Rmcf mice (e.g., myeloid cells) . Thus,
a decrease in efficiency of MCF formation and propagation
for M-MuLV and FM-MuLV in CXD2 mice would be rea-
sonable .
As shown in Fig. 1, lower panel, a pseudotypic mixture
of F-MuLV/F-MCF showed greatly accelerated disease in com-
parison to F-MuLV alone in Rmcf mice . Two aspects require
explanation . First, the fact that the F-MCF accelerated the
disease implies that it had an effect in vivo, even in Rmcf
mice. However, since the F-MCF was administered as a pseu-
dotypic mixture with F-MuLV, F-MCF genomes could in-
fect cells by way of ecotropic F-MuLV glycoprotein and
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